Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: DGX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on DGX, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 77,785 DGX shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 77,785 shares
    Change vs previous 13F -84,804 shares

    0.3% of the 13F portfolio, value $16,486,531.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 162,589 shares
    Change vs previous 13F -9,398 shares

    0.61% of the 13F portfolio, value $31,864,192.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 171,987 shares
    Change vs previous 13F +110,280 shares

    0.63% of the 13F portfolio, value $29,847,142.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 61,707 shares
    Change vs previous 13F +60,707 shares

    0.26% of the 13F portfolio, value $11,761,007.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,000 shares
    Change vs previous 13F +198 shares

    0.01% of the 13F portfolio, value $179,644.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 802 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $135,709.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).